PEDIARIX Vaccine | PEDIARIX (Diphtheria and Tetanus Toxoids and ...
Pediarix is a combination vaccine that protects your child from diphtheria, tetanus, pertussis, hepatitis B, and polio. It is given as 3 doses into the muscle at 6 weeks to 6 years old. Learn about the pros and cons, side effects, dosage, reviews, and more from GoodRx.
PEDIARIX | FDA - U.S. Food and Drug Administration
PEDIARIX is a 3-dose vaccine for diphtheria, tetanus, pertussis, hepatitis B, and poliomyelitis in infants born of hepatitis B surface antigen-negative mothers. Learn about the schedule flexibility, savings programs, supply reliability, and contraindications of PEDIARIX from GSK, the manufacturer.
Pediarix Vaccine Questions and Answers for Healthcare Providers| CDC
INDICATIONS AND USAGE. PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a 3-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers.
Pediarix Vaccine: Uses, Side Effects, Age Limits, Schedule - Drugs.com
Pediarix is a vaccine for children ages 6 weeks to 6 years old that helps prevent serious diseases caused by bacteria or virus. Learn about its uses, side effects, warnings, and interactions with other drugs and food.
PDF PEDIARIX is indicated for active immunization against ... - GSKpro
Pediarix is a combination product of DTaP, hepatitis B, and inactivated polio vaccines for children 6 weeks to 6 years old. It is licensed for the primary series only and should be followed with 4th and 5th doses of DTaP and a 4th dose of IPV. Learn about eligibility, contraindications, immunogenicity, and vaccine use recommendations from this web page.
Package Insert - PEDIARIX - U.S. Food and Drug Administration
PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers.
Pediarix (Diphtheria, Hepatitis B, Pertussis (Acellular), Polio, And ...
DTaP-IPV-HepB (Pediarix) contains DTaP, inactivated poliovirus (IPV), and Hepatitis B (recombinant) (HepB). Pediarix is approved by FDA for use as a 3-dose series in infants born to hepatitis B surface antigen (HBsAg)-negative mothers. Pediarix can be administered as early as age 6 weeks through 6 years.
About Combination Vaccines for Children | CDC
PEDIARIX is a vaccine for diphtheria, tetanus, pertussis, hepatitis B and poliomyelitis in infants. It is a 3-dose series given at 2, 4 and 6 months of age. The package insert provides information on indications, dosage, contraindications, warnings, adverse reactions and more.
Pediarix® Vaccine Guide - National Vaccine Support Group
Each 0.5-mL dose of Pediarix® (GlaxoSmithKline) includes the same diphtheria, tetanus, and pertussis components listed in Infanrix® above, the poliovirus components listed in Kinrix® above, and 10 µg of hepatitis B virus surface antigen (HBsAg).
DTaP-IPV-HepB (Pediarix, GSK) Archives | Immunize.org
A Clinician's Handbook for Childhood & Adult Immunizations in Georgia. Pediarix® DTaP / Hep B / IPV. Combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), Hepatitis B recombinant (Hep B), and inactivated polio virus vaccine (IPV). *Pediarix may only be used in children younger than age 7.